Literature DB >> 12756166

5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?

Luca Sigalotti, Maresa Altomonte, Francesca Colizzi, Massimo Degan, Maurizio Rupolo, Vittorina Zagonel, Antonio Pinto, Valter Gattei, Michele Maio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12756166     DOI： 10.1182/blood-2002-11-3458

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

1.  Cardiomyocyte marker expression in a human lymphocyte cell line using mouse cardiomyocyte extract.

Authors:  Zahra Vojdani; Sima Tavakolinejad; Tahereh Talaei-Khozani; Tahereh Esmaeilpour; Manuchehr Rasooli
Journal:  Hum Cell       Date:  2011-02-18       Impact factor: 4.174

2.  The biology of cancer testis antigens: putative function, regulation and therapeutic potential.

Authors:  Elisabetta Fratta; Sandra Coral; Alessia Covre; Giulia Parisi; Francesca Colizzi; Riccardo Danielli; Hugues Jean Marie Nicolay; Luca Sigalotti; Michele Maio
Journal:  Mol Oncol       Date:  2011-02-18       Impact factor: 6.603

Review 3.  Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.

Authors:  Stacey N Akers; Kunle Odunsi; Adam R Karpf
Journal:  Future Oncol       Date:  2010-05       Impact factor: 3.404

Review 4.  Decitabine: a review of its use in older patients with acute myeloid leukaemia.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

5.  Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

Authors:  Luca Sigalotti; Alessia Covre; Elisabetta Fratta; Giulia Parisi; Francesca Colizzi; Aurora Rizzo; Riccardo Danielli; Hugues J M Nicolay; Sandra Coral; Michele Maio
Journal:  J Transl Med       Date:  2010-06-11       Impact factor: 5.531

Review 6.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

Review 7.  A potential role for epigenetic modulatory drugs in the enhancement of cancer/germ-line antigen vaccine efficacy.

Authors:  Adam R Karpf
Journal:  Epigenetics       Date:  2006 Jul-Sep       Impact factor: 4.528

Review 8.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

9.  p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.

Authors:  Petra A Link; Maria R Baer; Smitha R James; David A Jones; Adam R Karpf
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

10.  Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.

Authors:  Tamer E Fandy; James G Herman; Patrick Kerns; Anchalee Jiemjit; Elizabeth A Sugar; Si-Ho Choi; Allen S Yang; Timothy Aucott; Tianna Dauses; Rosalie Odchimar-Reissig; Jonathan Licht; Melanie J McConnell; Chris Nasrallah; Marianne K H Kim; Weijia Zhang; Yezou Sun; Anthony Murgo; Igor Espinoza-Delgado; Katharine Oteiza; Ibitayo Owoeye; Lewis R Silverman; Steven D Gore; Hetty E Carraway
Journal:  Blood       Date:  2009-06-22       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.